Premarin/MPA + Premarin/MPA + Provera 10 mg
Phase 1Completed 0 watching 0 views this week๐ค Quiet
32
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postmenopause
Conditions
Postmenopause
Trial Timeline
Oct 1, 2007 โ Dec 1, 2007
NCT ID
NCT00543634About Premarin/MPA + Premarin/MPA + Provera 10 mg
Premarin/MPA + Premarin/MPA + Provera 10 mg is a phase 1 stage product being developed by Pfizer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00543634. Target conditions include Postmenopause.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00543634 | Phase 1 | Completed |
Competing Products
16 competing products in Postmenopause